Back to User profile » Professor Eeva Piitulainen
Papers published by Professor Eeva Piitulainen:
Signs of Hyperinflation and Ventilation Heterogeneity in Individuals With Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
Schramm GR, Wollmer P, Piitulainen E, Zaigham S, Tanash H
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:539-549
Published Date: 5 March 2025
COVID-19 in Individuals with Severe Alpha 1-Antitrypsin Deficiency
Tanash H, Tahiri Blakaj E, Piitulainen E, Zaigham S
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:2661-2669
Published Date: 9 December 2024
The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening
Hiller AM, Piitulainen E, Tanash H
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:43-52
Published Date: 5 January 2022
Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
Schramm GR, Mostafavi B, Piitulainen E, Wollmer P, Tanash HA
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3477-3485
Published Date: 23 December 2021
Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population
Tanash H, Ekström M, Basil N, Rönmark E, Lindberg A, Piitulainen E
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1245-1252
Published Date: 4 June 2020
Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
Hiller AM, Piitulainen E, Jehpsson L, Tanash H
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1075-1083
Published Date: 23 May 2019
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43–45 years
Mostafavi B, Piitulainen E, Tanash HA
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:525-530
Published Date: 28 February 2019
Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency
Mostafavi B, Diaz S, Piitulainen E, Stoel BC, Wollmer P, Tanash HA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3689-3698
Published Date: 8 November 2018
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years
Piitulainen E, Mostafavi B, Tanash HA
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:495-500
Published Date: 2 February 2017
Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
Tanash HA, Ekström M, Wagner P, Piitulainen E
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1663-1669
Published Date: 26 July 2016
Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS)
Torén K, Olin AC, Lindberg A, Vikgren J, Schiöler L, Brandberg J, Johnsson Å, Engström G, Persson HL, Sköld M, Hedner J, Lindberg E, Malinovschi A, Piitulainen E, Wollmer P, Rosengren A, Janson C, Blomberg A, Bergström G
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:927-933
Published Date: 2 May 2016